Cargando…

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device

OBJECTIVE: A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy in gynecologic cancers. We assessed whether the electrothermal bipolar vessel sealing device (EBVSD) could decrease the incidence of postoperative lymphocele secondary to pelvic lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Naotake, Ushijima, Kimio, Kawano, Kouichiro, Takemoto, Shuji, Nishio, Shin, Sonoda, Gounosuke, Kamura, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102742/
https://www.ncbi.nlm.nih.gov/pubmed/25045436
http://dx.doi.org/10.3802/jgo.2014.25.3.229
_version_ 1782327054102953984
author Tsuda, Naotake
Ushijima, Kimio
Kawano, Kouichiro
Takemoto, Shuji
Nishio, Shin
Sonoda, Gounosuke
Kamura, Toshiharu
author_facet Tsuda, Naotake
Ushijima, Kimio
Kawano, Kouichiro
Takemoto, Shuji
Nishio, Shin
Sonoda, Gounosuke
Kamura, Toshiharu
author_sort Tsuda, Naotake
collection PubMed
description OBJECTIVE: A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy in gynecologic cancers. We assessed whether the electrothermal bipolar vessel sealing device (EBVSD) could decrease the incidence of postoperative lymphocele secondary to pelvic lymphadenectomy. METHODS: A total of 321 patients with gynecologic cancer underwent pelvic lymphadenectomy from 2005 to 2011. Pelvic lymphadenectomy without EBVSD was performed in 134 patients, and pelvic lymphadenectomy with EBVSD was performed in 187 patients. We retrospectively compared the incidence of lymphocele and symptoms between both groups. RESULTS: Four to 8 weeks after operation, 108 cases of lymphocele (34%) were detected by computed tomography scan examination. The incidence of lymphocele after pelvic lymphadenectomy was 56% (75/134) in the tie ligation group, and 18% (33/187) in the EBVSD group. We found a statistically significant difference in the incidence of lymphocele between both groups (p<0.01). To detect the independent risk factor for lymphocele development, we performed multivariate analysis with logistic regression for three variables (device, number of dissected lymph nodes, and operation time). Among these variables, we found a significant difference (p<0.001) for only one device. CONCLUSION: Use of the EBVSD during gynecological cancer operation is useful for preventing the development of lymphocele secondary to pelvic lymphadenectomy.
format Online
Article
Text
id pubmed-4102742
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-41027422014-07-18 Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device Tsuda, Naotake Ushijima, Kimio Kawano, Kouichiro Takemoto, Shuji Nishio, Shin Sonoda, Gounosuke Kamura, Toshiharu J Gynecol Oncol Original Article OBJECTIVE: A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy in gynecologic cancers. We assessed whether the electrothermal bipolar vessel sealing device (EBVSD) could decrease the incidence of postoperative lymphocele secondary to pelvic lymphadenectomy. METHODS: A total of 321 patients with gynecologic cancer underwent pelvic lymphadenectomy from 2005 to 2011. Pelvic lymphadenectomy without EBVSD was performed in 134 patients, and pelvic lymphadenectomy with EBVSD was performed in 187 patients. We retrospectively compared the incidence of lymphocele and symptoms between both groups. RESULTS: Four to 8 weeks after operation, 108 cases of lymphocele (34%) were detected by computed tomography scan examination. The incidence of lymphocele after pelvic lymphadenectomy was 56% (75/134) in the tie ligation group, and 18% (33/187) in the EBVSD group. We found a statistically significant difference in the incidence of lymphocele between both groups (p<0.01). To detect the independent risk factor for lymphocele development, we performed multivariate analysis with logistic regression for three variables (device, number of dissected lymph nodes, and operation time). Among these variables, we found a significant difference (p<0.001) for only one device. CONCLUSION: Use of the EBVSD during gynecological cancer operation is useful for preventing the development of lymphocele secondary to pelvic lymphadenectomy. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014-07 2014-07-03 /pmc/articles/PMC4102742/ /pubmed/25045436 http://dx.doi.org/10.3802/jgo.2014.25.3.229 Text en Copyright © 2014. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tsuda, Naotake
Ushijima, Kimio
Kawano, Kouichiro
Takemoto, Shuji
Nishio, Shin
Sonoda, Gounosuke
Kamura, Toshiharu
Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title_full Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title_fullStr Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title_full_unstemmed Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title_short Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
title_sort prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102742/
https://www.ncbi.nlm.nih.gov/pubmed/25045436
http://dx.doi.org/10.3802/jgo.2014.25.3.229
work_keys_str_mv AT tsudanaotake preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT ushijimakimio preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT kawanokouichiro preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT takemotoshuji preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT nishioshin preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT sonodagounosuke preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice
AT kamuratoshiharu preventionoflymphoceledevelopmentingynecologiccancersbytheelectrothermalbipolarvesselsealingdevice